Neuronostatin, a somatostatin gene-encoded peptide, exerts important physiological and metabolic actions in diverse tissues. However, the direct biological effects of neuronostatin on pituitary function of humans and primates are still unknown. This study used baboon (Papio anubis) primary pituitary cell cultures, a species that closely models human physiology, to demonstrate that neuronostatin inhibits basal, but not ghrelin-/GnRH-stimulated, growth hormone (GH) and luteinizing hormone (LH) secretion in a dose-and time-dependent fashion, without affecting the secretion of other pituitary hormones (prolactin, ACTH, FSH, thyroid-stimulating hormone (TSH)) or changing mRNA levels. Actions of neuronostatin differs from somatostatin which in this study reduced GH/PRL/ACTH/LH/TSH secretion and GH/PRL/POMC/LH gene expression. Remarkably, we found that inhibitory actions of neuronostatin are likely mediated through: (1) the orphan receptor GPCR107 (found to be highly expressed in pituitary compared to somatostatin-receptors), (2) common (i.e. adenylyl cyclase/protein kinase A/MAPK/extra-/intracellular Ca 2+ mobilization, but not phospholipase C/protein kinase C/mTOR) and distinct (i.e. PI3K) signaling pathways than somatostatin and; (3) dissimilar molecular mechanisms than somatostatin (i.e. upregulation of GPCR107 and downregulation of GHS-R/Kiss1-R expression by neuronostatin and, upregulation of sst1-5 expression by somatostatin). Altogether, the results of this study provide the first evidence that there is a functional neuronostatin signaling circuit, unique from somatostatin, which may work in concert with somatostatin to fine-tune hormone release from somatostropes and gonadotropes.
Introduction
Neuronostatin (NST), a recently described peptide hormone encoded in the preprosomatostatin gene but without amino-acid homology to somatostatin (SST) (Samson et al. 2008) , has been shown to exert important physiological actions in diverse tissues (Hua et al. 2009 , However, measurement of SST and NST in the same samples indicated variations in the ratio of both peptides in different tissues, suggesting differential processing of these two peptides from the same precursor (Samson et al. 2008) . Although it is clear that the actions of SST are mediated through activation of the SST receptor subtypes (sst1-sst5) (Ben-Shlomo & Melmed 2010 , VazquezBorrego et al. 2017 , it has been reported that NST failed to activate any of the sst-subtypes in an in vitro system (Samson et al. 2008) , suggesting that NST and SST might exert different functions, or that the associated activities might be independent from each other. In fact, evidence indicating that NST acts through the G-protein-coupled receptor 107 (GPCR107) to exert some of its functions (Yosten et al. 2012 , Elrick et al. 2016 ) is available.
Irrespective of the receptors involved, NST has been shown to regulate metabolic function at the central (i.e. acting as a neuropeptide in the cerebellum and hypothalamus) and the peripheral levels (i.e. heart, pancreas, gastrointestinal tract, etc.), including regulation of neuronal migration, hypothalamic neuron firing, modulation of food/water intake and blood pressure (Samson et al. 2008 , Hua et al. 2009 , Dun et al. 2010 , Carlini et al. 2011 , Yosten et al. 2011 , Su et al. 2012 , Salvatori et al. 2014 . In fact, some of the actions of NST are common to SST (Samson et al. 2008 , Hua et al. 2009 ). In spite of the genetic and putative functional link between NST and SST, the actions of NST on pituitary function, also known as the 'master gland' of the body, has not been explored in detail despite the fact that SST was originally identified based on its ability to suppress the secretion of growth hormone (GH) and subsequent studies have shown that SST also suppresses the secretion of other pituitary hormones (Brazeau et al. 1973 , Eigler & Ben-Shlomo 2014 , Vazquez-Borrego et al. 2017 . In addition, NST induces c-Fos expression in the pituitary (Samson et al. 2008) and is expressed in the arcuate nucleus of the hypothalamus which represents an important site for the control of the function of different pituitary cell types (Dun et al. 2010) . Based on these associations, the current study sought to explore for the first time the direct effects of NST on pituitary function using primary pituitary cell cultures from baboons (Papio anubis), a species that closely models human physiology (McClure 1984 , Comuzzie et al. 2003 .
Specifically, in this study, we compared the direct effects of NST to SST on the pituitary hormone (GH, prolactin (PRL), follicle-stimulating hormone (FSH), luteinizing hormone (LH), adrenocorticotropic hormone (ACTH) and thyroid-stimulating hormone (TSH)) release and expression. In addition, to better understand the mechanisms behind these actions, we used pharmacological inhibitors to various intracellular signaling pathways previously shown to be important in the actions of SST (adenylyl cyclase (AC), protein kinase A (PKA), phospholipase C (PLC), protein kinase C (PKC), extracellular Ca 2+ L-type channels, intracellular Ca 2+ channels, mitogen-activated protein kinases (MAPK), mammalian target of rapamycin (mTOR) and phosphatidylinositol-3-kinase (PI3K)). Finally, we evaluated the impact of NST and SST on the expression of key receptors and transcriptional factors involved in the normal functioning of the pituitary cell types.
Materials and methods

Reagents
All the material (reagents, peptides, inhibitors of signaling pathways, etc.) used in this study were purchased from Sigma-Aldrich unless otherwise specified. Human amidated (Ala-Pro-Ser-Asp-Pro-Arg-Leu-Arg-Gln-Phe-LeuGln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-NH 2 ) and SST-14 (SST; Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-SerCys; with a disulfide bridge: Cys3-Cys14) were purchased from Phoenix Pharmaceuticals (Burlingame, CA, USA). α-Minimum essential media, HEPES, horse serum and penicillin-streptomycin were obtained from Invitrogen. U73122 was purchased from Cayman Chemical.
Animals and tissue collection
Primate (olive baboon; Papio anubis; n = 5, 8-10 years of age; 15.0-31.8 kg of weight) pituitaries and hypothalami were obtained from randomly cyclic control females from a breeding colony at the University of Illinois at Chicago within 15 min after sodium pentobarbital overdose as previously reported (Cordoba-Chacon et al. 2012a , Sarmento-Cabral et al. 2017 . All animals in which tissues were taken were covered by protocols approved by the University of Illinois at Chicago Institutional Animal Care and Use Committee. Hypothalami were immediately frozen in liquid nitrogen and stored at −80°C until extraction for total RNA (see the 'RNA isolation, reversetranscription and qrtPCR of baboon transcripts' section below). Pituitaries were placed in sterile cold (4°C) α-MEM (media supplemented with 0.15% BSA, 6 nM HEPES, 10 IU/mL penicillin and 10 µg/mL streptomycin). Then, the pars distalis of the pituitary was isolated, washed twice in fresh media and cut into small pieces (~20-40 mg) with surgical blades under sterile conditions. One fragment of the pituitary was rapidly frozen in liquid nitrogen and stored at −80°C until extraction for total RNA (see the 'RNA isolation, reverse-transcription and qrtPCR of baboon transcripts' section below), while the remaining pieces of the pituitary were transported to the laboratory in sterile cold α-MEM, minced into 1-2 mm 3 pieces under sterile conditions and then, incubated in 30-mL S-MEM medium complemented with 0.3% trypsin (Becton, Dickinson and Company, Sparks, MD, USA) in a spinner flask (Bellco Glass, Vineland, NJ, USA) for 2 h at 37°C under gentle shaking to obtain dispersed single cells for culture (see the 'Primary pituitary cell cultures' section below), as previously reported (Luque et al. 2006 , Kineman & Luque 2007 . To avoid fibroblast contamination, suspensions of dispersed pituitary cells were filtered through a nylon gauze of 130-µM-mesh, and cultured in media with d-valine (replaced for l-valine) to selectively inhibit fibroblast proliferation/overgrowth. In addition, visual inspection of primary cell cultures at the time of experimental assays showed no sign of cells displaying the typical fibroblast-like morphology.
Primary pituitary cell cultures
Single cells (50,000-200,000 cells/well) were plated onto 48-or 24-well plates in media containing 10% fetal horse serum. After 36-h incubation (37°C), media were removed and cells pre-incubated for 1 h with fresh, warm, serumfree media alone to stabilize basal hormone secretion. After this pre-incubation period, cells were incubated with serum-free media containing the following treatments: (1) NST alone (0.01-10 nM; dose-response experiment; 4 h incubation); (2) NST alone (10 nM) for 30 min, 4, 12 and 24 h (time course experiment); (3) NST or SST alone (10 nM) for 4 h and 24 h (experiment for the comparison between the two somatostatin gene-encoded peptides); (4) NST or SST alone (10 nM) or in combination with acylated-ghrelin (10 nM) or gonadotropin-releasing hormone (GnRH, 10 nM) for 4 h.
In order to study and compare the intracellular signaling pathways involved in the NST-and SSTmediated actions on GH and LH release, serum-free media containing inhibitors of different intracellular signaling pathways (AC (MDL-12330A; 10 µM), PKA (H89; 15 µM), PLC (U73122; 50 µM), PKC (Go6983; 20 μm), extracellular Ca 2+ L-type channels (nifedipine; 1 µM), intracellular Ca 2+ channels (thapsigargin; 10 µM), MAPK (PD-98059; 10 μm), mTOR (rapamycin; 10 nm) and PI3K (wortmannin; 1 μm)) were incubated for 90 min after the 1-h pre-incubation period with serum-free media, and then, the media were replaced with media with the specific inhibitor alone (vehicle) or media with the inhibitor containing NST or SST (10 nM) and incubated for an additional 4 h. Additional controls consisted of serum-free media alone or media with NST or SST (in all cases without inhibitors). Doses for acylated-ghrelin, SST, GnRH or inhibitors of intracellular signaling pathways were selected based on previous studies (Kineman & Luque 2007 , CordobaChacon et al. 2011 , 2012b .
At the end of the corresponding incubation periods with the different treatments, media were collected for hormone analysis using commercial ELISAs (see the 'Hormone release analysis' section below) and, in selected cases, cells were processed for total RNA recovery and assessment of mRNA levels by quantitative real-time PCR (qPCR; see the 'RNA isolation, reverse-transcription and qrtPCR of baboon transcripts' section below).
Hormone release analysis
GH, PRL, ACTH, LH, FSH and TSH hormone concentrations in the culture media were measured using human commercial ELISAs (human: GH, PRL, ACTH, LH, FSH and TSH (reference numbers: EIA-1787, EIA-1291, EIA-3647, EIA-1289, EIA-1288 and EIA-1790, respectively; DRG, Mountainside, NJ, USA)). All the assays were performed following the manufacturer's instructions where the information regarding specificity, detectability and reproducibility for each of the assays can be accessed at the websites of the indicated company.
RNA isolation, reverse-transcription and qrtPCR of baboon transcripts
Tissues (pituitary and hypothalamus) and pituitary cell cultures from baboons were processed for recovery of total RNA and the subsequent quantification of the amount of RNA recovered using kits and methods previously described (Sarmento-Cabral et al. 2017) . Briefly, total RNA was reverse-transcribed in a 20-µL volume using random-hexamer primers and the cDNA First Strand Synthesis kit (MRI Fermentas, Hannover, MD, USA). cDNAs were amplified by qrtPCR using a Stratagene Mx3000p real-time PCR machine and the brilliant SYBR Green QPCR Master Mix (Stratagene). To estimate mRNA copy number, samples were run against specific synthetic standards (1-10 6 copies of synthetic cDNA template for each transcript of interest) run on the same plate. Details regarding the development, validation and application of a qrtPCR to measure expression levels of baboon transcripts, including cyclophilin-A (used as a housekeeping gene), have been reported previously (Luque et al. 2006 , Kineman & Luque 2007 . Specific sets of primer sequences used in this study have been previously reported (Luque et al. 2006 , Cordoba-Chacon et al. 2012a . New baboon primer sequences were used in the present study to amplify baboon sst3 (sense: CCAGCCCTTCAGTCACCA; antisense:
CCGAAGGGCCAGTAAGACA; product size: 115 bp; accession number: EU156181.1), sst4 (sense: TCTTTGTGCTCTGCTGGATG; antisense: AACCATAGAGTACGGGGTTGG; product size: 138 bp; accession number: EU156182.1) and GPCR107 (sense:
GCATCAGCAACAGATGGAAA; antisense: GGAACAGCGAGTTTGAGGAG; product size: 131 bp; accession number: XM_003911188.4). To control for variations in the amount of RNA used in the RT reaction and the efficiency of the RT reaction, mRNA copy numbers of the baboon transcripts analyzed were adjusted by cyclophilin-A expression, where baboon cyclophilin-A mRNA levels did not significantly vary between experimental groups (data not shown).
Statistical analysis
Samples from all groups within an experiment were processed at the same time. To normalize values within each treatment and minimize intragroup variations in the different experiments (i.e. different age of the tissue donor, stage of the estrus cycle and/or to the metabolic environment, etc.), the values obtained were compared with vehicle-treated control cultures (set at 100%), where this style of data presentation does not alter the relative differences between NST-or SST-treated and vehicle-treated groups. Results were obtained from at least three separate independent experiments carried out on different days and with different cell preparations (3-4 replicate culture wells/treatment/experiment).
Differences between groups were assessed by one-way ANOVA (or two-way ANOVA when the intracellular signaling pathways, with treatments with and without (controls) specific inhibitors, were studied) followed by a Newman-Keuls test for multiple comparisons. P ≤ 0.05 was considered significant. All data are expressed as means ± s.e. All statistical analyses were performed using the GB-STAT software package (Dynamic Microsystems, Silver Spring, MD, USA).
Results
Direct effect of NST on pituitary hormone release
Incubation of cultured baboon pituitary cells with increasing doses of NST for 4 h revealed clear inhibitory effects on GH and LH release in a concentrationdependent manner (at doses equal to or above 10 −9 M for GH and 10 −7 M for LH; Fig. 1 ). Conversely, NST failed to alter basal PRL, ACTH, FSH or TSH release at all the doses tested ( Fig. 1) . Based on these results, the dose of NST that caused a maximal decrease of both GH and LH release, 10 −7 M, was chosen to further analyze the action of the peptide on baboon pituitary function.
Interestingly, treatment with 10 −7 M NST, for different incubation times (30 min, 4, 12 and 24 h), revealed an inhibitory effect on both GH and LH, but not PRL, ACTH, FSH or TSH, release between 4 h and 12 h, whereas hormone release was not impacted after short-term (30 min) or long-term (24 h) incubation (Fig. 2) .
Comparison between the effects of NST and SST on pituitary hormone expression and release
In a separate experiment, we confirmed that NST treatment (10 −7 M) was able to significantly reduce GH and LH secretion at 4 h, but not at 24 h (Fig. 3A) , without impacting the release of other pituitary hormones or 
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altering gene expression (GH, PRL, pro-opiomelanocortin (POMC, the precursor of ACTH), FSH, LH or TSH) (Fig. 3B ). In this set of studies, we compared these actions to SST at the same dose (10 −7 M) and found that SST was able to significantly reduce GH, PRL, ACTH and LH secretion at both 4 h and 24 h, as well as TSH release at 4 h, but not at 24 h, of incubation (Fig. 3A) . Interestingly, the inhibitory effect of SST on basal GH, but not LH, release was significantly higher than that exerted by NST at 4 h (Fig. 3A) . Moreover, SST treatment was also able to 
significantly reduce GH, PRL, POMC and LH, but not FSH or TSH, expression at 24 h of incubation (Fig. 3B) .
It should be mentioned that the inhibitory effect of NST or SST on somatotrope function (or on lactotrope function by SST) does not seem to be mediated by a reduction in pituitary transcription factor-1 (Pit-1) mRNA production (a critical factor for normal development and function of somatotrope and lactotrope cells (Andersen & Rosenfeld 2001) ; Fig. 3B ).
Interaction of NST or SST with key regulators of GH and LH secretion: ghrelin and GnRH in a non-human primate model
We next tested the direct effects of 4 h of incubation with NST or SST alone or in combination with a primary stimulatory factor of somatotrope (i.e. ghrelin (Kineman & Luque 2007) ) or gonadotrope (i.e. GnRH ) function (Fig. 4) . Specifically, we found that treatments with NST or SST alone inhibited GH and LH release, whereas ghrelin or GnRH alone stimulated GH or LH release in primary pituitary cell cultures, respectively (Fig. 4) . The stimulatory effects of ghrelin on GH and of GnRH on LH secretion were fully blocked by the co-administration with SST, but not with NST (Fig. 4) . Interestingly, we found that NST augmented the inhibitory action of SST on ghrelin-stimulated GH release ( Fig. 4; left panel) , while it did not impact the actions of SST on GnRH-stimulated LH release ( Fig. 4; right panel) .
Intracellular signaling pathways involved in NST-and SST-mediated GH and LH release in a non-human primate model
The use of pharmacological inhibitors indicates that NST and SST inhibit GH and LH release through almost identical signaling pathways (Fig. 5A and B, respectively) . Given the limited source of baboon cell preparations, we were able to study only some selected signaling routes. Specifically, administration of these inhibitors alone did not modify basal GH or LH release (Fig. 5A or B, respectively; control-columns). Our results indicate that the inhibitory effect of NST and SST on GH and LH release is mediated through AC/PKA, MAPK and extra-/ intracellular Ca 2+ influx because incubation with specific blockers of these routes, but not with PLC/PKC or mTOR inhibitors, completely blocked the inhibitory effect of NST on GH and LH secretion (Fig. 5A or B, respectively; NST and SST columns). Interestingly, blockade of PI3K activity completely abolished the inhibitory effect of SST, but not of NST, on GH secretion (Fig. 5A) .
Presence of receptors for NST and SST in the pituitary, and homologous and heterologous regulation of these receptors GPCR107 was highly expressed in baboon pituitaries (Fig. 6A) , and this expression was higher than that found in the hypothalamus (where NST has been previously shown to be highly produced and to exert relevant functions (Samson et al. 2008) ). Interestingly, we also found that the expression level of GPCR107 in pituitaries from female baboons was remarkably higher than that of the various sst-subtypes (sst1-5; Table 1 ). The relevant expression levels of the sst-subtypes shown in this study are consistent with previous reports in baboon and human (sst5 > sst2 > sst1 > sst3 > sst4; (Neto et al. 2009 , CordobaChacon et al. 2012b )) ( Table 1) .
To confirm that primary pituitary cells of baboons maintain a differentiated phenotype after dispersion and culture, absolute mRNA levels (copy numbers per 0.05 µg total RNA) of NST and SST receptors and cyclophilin-A were compared between whole-tissue extracts (in vivo conditions; Table 1 ) and extracts prepared from pituitary cell cultures (in vitro conditions; 4 h after incubation in serum-free medium). Results indicated that transcript levels did not vary significantly between in vivo and in vitro samples (data not shown), indicating that the cell preparation and culture conditions did not impact the expression of pituitary receptors for NST or SST, which support that the culture system used allows for the maintenance of correct functions of the different pituitary cell types. As previously reported (Cordoba-Chacon et al. 2012a), we observed that 4 h of incubation with SST (10 −7 M) markedly increased the expression of sst1, sst2 and sst5 in baboon pituitary cultures ( Fig. 6B; left panel) . Moreover, 
Discussion
NST, a recently discovered amidated peptide encoded by the somatostatin gene, has been shown to exert diverse activities at the central and peripheral level (Samson et al. 2008 , Hua et al. 2009 , Carlini et al. 2011 , Yosten et al. 2011 , Su et al. 2012 , Salvatori et al. 2014 . However, information about the direct role that NST exerts at the level of the pituitary gland, a true sensor of whole body function integrating central and peripheral signals and often referred to as the 'master endocrine gland', is quite limited. Specifically, to the best of our knowledge, the effect of NST at the pituitary level has been only derived from a single series of studies showing that treatment with NST increased c-fos immunoreactivity in rat pituitaries, but NST did not impact GH, PRL, ACTH or LH release from primary rat pituitary cell cultures after a short period of incubation (30 min) (Samson et al. 2008) . Therefore, the question remains: can NST directly regulate pituitary function (basal and stimulated hormone release and hormone gene expression) if applied for longer periods and at different doses? To address this question, in the current study, we examined whether NST could directly impact hormone release/expression in primary pituitary cell cultures from normal baboons (Papio anubis), a primate model that closely models human physiology and is therefore of interest for translational medicine (McClure 1984 , Comuzzie et al. 2003 . Our current findings are the first to show that NST inhibits somatotrope and gonadotrope function. Specifically, we showed that NST acts selectively to suppress basal GH and LH release, without altering GH and LH gene expression, whereas these selected effects differ from the broad inhibitory effects of SST on basal and stimulated pituitary hormone release and synthesis, as shown by our current studies and as previously reported (Weeke et al. 1975 , Wildt et al. 1981 , CordobaChacon et al. 2011 , 2012b , SarmentoCabral et al. 2017 . It should be noted that although some reports (Yu et al. 1997 , Milosevic et al. 2004 ), including the current study, show that SST has no effect on FSH release and synthesis, other reports have shown that SST is able to inhibit FSH (Evans 1999) . In this sense, although LH and FSH are known to be co-stored in a subpopulation of bihormonal gonadotropes and are often co-regulated and released in response to different factors (Evans 1999) , previous studies in non-human primate models have demonstrated that FSH secretion can follow a markedly different pattern from that of LH (Wildt et al. 1981) , as it has been observed in the current study.
To the best of our knowledge, this is the first report studying, in a cell culture system, the direct interaction between SST and NST, and also the interaction of NST and/or SST with other primary regulators of pituitary function. We found that SST, but not NST, blocked ghrelin-stimulated GH release and GnRH-stimulated LH release, which is consistent with previous studies reported with SST (Kineman & Luque 2007 , 2012b , and with the only report published to date indicating that neither ghrelinstimulated GH release nor GnRH-stimulated LH release was affected by NST treatment in rats cultured anterior pituitary cells (Samson et al. 2008 ). Interestingly, NST was able to augment the inhibitory effect of SST on ghrelinstimulated GH, but GnRH-stimulated LH release. Therefore, our data are the first to provide evidence that NST might act together with SST to fine-tune somatotrope function. These results are novel and, although the mechanisms and physiologic relevance behind these actions remain unknown, set the stage for future investigations.
Our report also demonstrates for the first time that the actions of NST are mediated by AC/PKA, MAPK and extra-/intracellular Ca 2+ mobilization, a complex set of second messenger pathways which almost parallels that found to be mediated by SST. We also confirm previous reports (Cordoba-Chacon et al. 2012b) , that activation of AC and MAPK pathways is required by SST to exert its action on GH release. Interestingly, we also found that the inhibitory actions of SST, but not NST, on GH secretion also require PI3K signaling which might suggest that activation of this pathway by SST could be important in mediating some of the unique actions associated to SST (not shared with NST). Taken together, these results strongly indicate that the mechanism of action of NST clearly differs from SST at the pituitary. This differential effect may be related to the fact that SST is a cyclic, non-amidated peptide, and NST is a non-cyclic, amidated peptide. In fact, the presence or absence of amidation enzymes or degrading enzymes could dictate the expression levels and activity of NST and SST in a tissue-specific fashion (Samson et al. 2008) . Indeed, the amidation process of NST seems to be essential to exert some of its physiological actions, including its influence in gastric emptying and gastrointestinal transit, hypertension activity, antinociceptive effect and depressive behavior (Yang et al. 2011a ,b, Yosten et al. 2011 , Su et al. 2012 . In addition, differential effects of NST vs SST on pituitary function are likely mediated by different receptors. Specifically, SST exerts its inhibitory effects on pituitary function via somatostatin receptor subtypes sst1-5 (Samson et al. 2008 , Ben-Shlomo & Melmed 2010 , Vazquez-Borrego et al. 2017 . However, it was previously reported that NST failed to activate sst1-5 in an in vitro experimental system (Samson et al. 2008 ), but could interact and be functionally connected with the orphan receptor GPCR107 (Yosten et al. 2012 , Elrick et al. 2016 . Importantly, we found that GPCR107 is highly expressed in the baboon pituitary (mRNA levels greater than those for all sst-subtypes) and pituitary GPCR107 expression (but not sst1-5 expression) is increased by NST treatment, where ligand-mediated upregulation of canonical receptors has been observed for other pituitary regulatory peptides (i.e. SST/sst1-5 (Luque et al. 2004a , Cordoba-Chacon et al. 2012a , and as occurs in the present study; GHRH/GHRH-R and ghrelin/GHS-R (Luque et al. 2004b , Cordoba-Chacon et al. 2012a . In fact, upregulation of GPCR107 in response to NST treatment was also observed in pancreatic cell cultures (Elrick et al. 2016) . Noteworthy is the observation that NST, but not SST, exerted a heterologous regulation on the expression of key receptors for somatotrope (GHS-R) and gonadotrope (Kiss1-R) function. These results may be (patho)physiologically relevant in humans in that we have previously shown that the hormonal/clinical control of patients with different endocrine pathologies (i.e. pituitary adenomas, neuroendocrine and thyroid tumors, etc.) that are treated with SST analogues is directly associated with the amount of and ratio between the expression of pituitary sst-subtypes (Taboada et al. 2007 , Puig-Domingo et al. 2014 , Luque et al. 2015 , Sampedro-Nunez et al. 2016 . Most importantly, this report demonstrated for the first time that NST inhibited basal GH and LH release and that NST augmented the inhibitory action of SST on basal GH release which provide a potentially useful tool to develop new therapeutic targets to treat patients with pituitary tumors (i.e. combination of SSAs with NST or NST-analogues). In any case, our current data further extend those original observations, suggesting that the physiological actions of NST might include a pituitary site of action as well. In fact, based on the results of the present study as well as on previous results demonstrating that the actions of multiple peptides acting at the pituitary level are similar when tested in vivo and in vitro (Brazeau et al. 1973 , Kineman & Luque 2007 , Vazquez-Borrego et al. 2017 , it is tempting to speculate that NST would exert its pituitary actions on selected pituitary cell types through different, at least partially dissimilar, mechanisms and/or signaling pathways than those involved in the effects of SST.
Summary
This study supplies the first evidence that NST can directly control pituitary function. The actions of NST are distinct from its older sibling peptide, SST, in that the inhibitory actions of NST are isolated to inhibition of basal GH and LH release, whereas SST has a more broad impact on basal and stimulated pituitary hormone release and gene expression. These actions of NST may be exerted via GPCR107, based on the previous reports (Yosten et al. 2012 , Elrick et al. 2016 , as well as on the current finding that GPCR107 is highly expressed in the primate pituitary and is regulated by NST. Although NST and SST may signal through different receptors to suppress GH and LH release, the downstream intracellular signals required for these actions may be in large part mediated via AC/PKA, MAPK and extra-/intracellular Ca 2+ mobilization. Given these effects on NST were observed in a primate model, that could be readily translated to human patho(physiology), these results lay a solid foundation to pursue question related to the importance of NST on
